Lakefront Biotherapeutics (LKFT) Change in Accured Expenses (2018 - 2025)
Lakefront Biotherapeutics (LKFT) posted quarterly Change in Accured Expenses of -$163042.1 for Q1 2025, down 100.62% quarter-over-quarter from -$81268.2 in Q3 2024.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Change in Accured Expenses (2018 - 2025) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Change in Accured Expenses for 4 consecutive years, with -$163042.1 the latest figure, recorded in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Lakefront Biotherapeutics | 1.88 Bn | 1.88 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -163,042.09 |
| Sep 30, 2024 | -81,268.24 |
| Sep 30, 2019 | -2.15 Mn |
| Jun 30, 2019 | -2.62 Mn |
| Mar 31, 2019 | -1.37 Mn |
| Sep 30, 2018 | -943,297.76 |
| Jun 30, 2018 | -455,895.77 |
| Mar 31, 2018 | -417,701.15 |